Production (Stage)
MediPharm Labs Corp.
MEDIF
$0.0541
-$0.0033-5.75%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -52.71% | -40.26% | -5.51% | 4.62% | -14.81% |
| Total Receivables | 13.67% | 17.54% | -51.91% | -59.19% | -53.14% |
| Inventory | 1.38% | -20.51% | -11.60% | -17.95% | 19.12% |
| Prepaid Expenses | -29.51% | -38.71% | -25.55% | -32.34% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 270.04% | 116.17% | 100.73% | 9.72% | -47.48% |
| Total Current Assets | -13.85% | -17.11% | -16.94% | -21.44% | -21.68% |
|
|
|||||
| Total Current Assets | -13.85% | -17.11% | -16.94% | -21.44% | -21.68% |
| Net Property, Plant & Equipment | -27.62% | -30.42% | -22.17% | -25.12% | 38.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -22.79% | -24.05% | -16.52% | 3.10% | 2,493.95% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -39.26% | -41.72% | -- | -- | -- |
| Total Assets | -19.91% | -22.87% | -17.78% | -21.25% | -1.38% |
|
|
|||||
| Total Accounts Payable | 27.30% | 82.57% | 45.03% | -31.12% | 51.36% |
| Total Accrued Expenses | -47.54% | -16.02% | -3.78% | -18.81% | -0.97% |
| Short-term Debt | -99.34% | -88.75% | -76.78% | 172.39% | 1,408.26% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -5.75% | -40.07% | -73.02% | -58.42% | 15.88% |
| Total Finance Division Other Current Liabilities | -11.63% | -17.90% | -35.27% | -7.64% | -4.89% |
| Total Other Current Liabilities | -11.63% | -17.90% | -35.27% | -7.64% | -4.89% |
| Total Current Liabilities | -26.81% | -11.32% | -15.33% | -7.06% | 35.29% |
|
|
|||||
| Total Current Liabilities | -26.81% | -11.32% | -15.33% | -7.06% | 35.29% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -99.34% | -88.75% | -76.78% | 172.39% | 1,408.26% |
| Capital Leases | -49.53% | -32.18% | -55.65% | -35.16% | 221.80% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -26.92% | -11.46% | -15.58% | -18.46% | 35.69% |
|
|
|||||
| Common Stock & APIC | -5.42% | -7.77% | 0.61% | -2.72% | 4.71% |
| Retained Earnings | 1.89% | 2.66% | -7.01% | -4.45% | -8.07% |
| Treasury Stock & Other | -5.63% | -8.51% | 3.02% | 0.10% | 2.08% |
| Total Common Equity | -18.31% | -25.22% | -18.29% | -21.94% | -7.17% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.31% | -25.22% | -18.29% | -21.94% | -7.17% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.31% | -25.22% | -18.29% | -21.94% | -7.17% |
|
|
|||||